NCT04003506View on ClinicalTrials.gov

Effectiveness of Adductor Canal Block Using Liposomal Bupivacaine

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Pain, Postoperative
Interventions
DRUG

Liposomal bupivacaine

LIA with ACB will be given using 10ml of 1.33% liposomal bupivacaine + 10ml 0.5% standard bupivacaine

DRUG

Bupivacaine Injection

LIA with ACB will be given using 20ml 0.5% standard bupivacaine

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER